Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord

Biochemical and Biophysical Research Communications

Volumn 378, Issue 2, 2009, Pages 308-312

  Hirakawa, Akihiro ^a,b   Shimizu, Katsuji ^b   Fukumitsu, Hidefumi ^a   Furukawa, Shoei ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BBB scale; Central nervous system (CNS); Hemi transection; Inducible nitric oxide synthase (iNOS); Locomotor function; Nitric oxide (NO); Pyrroloquinoline quinone (PQQ); Spinal cord injury (SCI)

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PYRROLOQUINOLINEQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; FEMALE; GENE EXPRESSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; TREATMENT RESPONSE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; AXONS; FEMALE; GENE EXPRESSION; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE TYPE II; PQQ COFACTOR; RATS; RATS, WISTAR; SPINAL CORD INJURIES;

RATTUS;

EID: 57049186532     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.045     Document Type: Article

References (39)

1. Farooque M., Isaksson J., and Olsson Y. Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice. J. Neurotrauma 18 (2001) 105-114
2. Conti A., Miscusi M., Cardali S., Germano A., Suzuki H., Cuzzocrea S., and Tomasello F. Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 54 (2007) 205-218
3. Buisson A., Plotkine M., and Boulu R.G. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br. J. Pharmacol. 106 (1992) 766-767
4. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20 (1997) 132-139
5. Hamada Y., Ikata T., Katoh S., Tsuchiya K., Niwa M., Tsutsumishita Y., and Fukuzawa K. Roles of nitric oxide in compression injury of rat spinal cord. Free Radic. Biol. Med. 20 (1996) 1-9
6. Matsuyama Y., Sato K., Kamiya M., Yano J., Iwata H., and Isobe K. Nitric oxide: a possible etiologic factor in spinal cord cavitation. J. Spinal Disord. 11 (1998) 248-252
7. Killgore J., Smidt C., Duich L., Romero-Chapman N., Tinker D., Reiser K., Melko M., Hyde D., and Rucker R.B. Nutritional importance of pyrroloquinoline quinone. Science 245 (1989) 850-852
8. Steinberg F.M., Gershwin M.E., and Rucker R.B. Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J. Nutr. 124 (1994) 744-753
9. Stites T.E., Mitchell A.E., and Rucker R.B. Physiological importance of quinoenzymes and the O-quinone family of cofactors. J. Nutr. 130 (2000) 719-727
10. Bishop A., Gallop P.M., and Karnovsky M.L. Pyrroloquinoline quinone: a novel vitamin?. Nutr. Rev. 56 (1998) 287-293
11. Zhang Y., and Rosenberg P.A. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur. J. Neurosci. 16 (2002) 1015-1024
12. Aizenman E., Hartnett K.A., Zhong C., Gallop P.M., and Rosenberg P.A. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-d-aspartate receptor redox modulatory site. J. Neurosci. 12 (1992) 2362-2369
13. Aizenman E., Jensen F.E., Gallop P.M., Rosenberg P.A., and Tang L.H. Further evidence that pyrroloquinoline quinone interacts with the N-methyl-d-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci. Lett. 168 (1994) 189-192
14. Jensen F.E., Gardner G.J., Williams A.P., Gallop P.M., Aizenman E., and Rosenberg P.A. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience 62 (1994) 399-406
15. Zhang Y., Feustel P.J., and Kimelberg H.K. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res. 1094 (2006) 200-206
16. Hashimoto M., Nitta A., Fukumitsu H., Nomoto H., Shen L., and Furukawa S. Inflammation-induced GDNF improves locomotor function after spinal cord injury. Neuroreport 16 (2005) 99-102
17. Basso D.M., Beattie M.S., and Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139 (1996) 244-256
18. Tan A.M., Colletti M., Rorai A.T., Skene J.H., and Levine J.M. Antibodies against the NG2 proteoglycan promote the regeneration of sensory axons within the dorsal columns of the spinal cord. J. Neurosci. 26 (2006) 4729-4739
19. Salisbury S.A., Forrest H.S., Cruse W.B., and Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature 280 (1979) 843-844
20. He K., Nukada H., Urakami T., and Murphy M.P. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem. Pharmacol. 65 (2003) 67-74
21. Sanchez R.M., Wang C., Gardner G., Orlando L., Tauck D.L., Rosenberg P.A., Aizenman E., and Jensen F.E. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J. Neurosci. 20 (2000) 2409-2417
22. Scanlon J.M., Aizenman E., and Reynolds I.J. Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur. J. Pharmacol. 326 (1997) 67-74
23. Faden A.I., and Simon R.P. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23 (1988) 623-626
24. Liu D., Thangnipon W., and McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 547 (1991) 344-348
25. Yanase M., Sakou T., and Fukuda T. Role of N-methyl-d-aspartate receptor in acute spinal cord injury. J. Neurosurg. 83 (1995) 884-888
26. Faden A.I., Lemke M., Simon R.P., and Noble L.J. N-Methyl-d-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: behavioral, anatomic, and neurochemical studies. J. Neurotrauma 5 (1988) 33-45
27. Karadottir R., Cavelier P., Bergersen L.H., and Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438 (2005) 1162-1166
28. Micu I., Jiang Q., Coderre E., Ridsdale A., Zhang L., Woulfe J., Yin X., Trapp B.D., McRory J.E., Rehak R., Zamponi G.W., Wang W., and Stys P.K. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439 (2006) 988-992
29. Matute C. Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol. Med. 12 (2006) 289-292
30. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7 (1987) 369-379
31. Miscusi M., Ebner F., Ceccariglia S., Menegazzi M., Mariotto S., Berra L., Del Fa A., Gangitano C., Lauretti L., Missori P., Delfini R., and Suzuki H. Early nuclear factor-kappaB activation and inducible nitric oxide synthase expression in injured spinal cord neurons correlating with a diffuse reduction of constitutive nitric oxide synthase activity. J. Neurosurg. Spine 4 (2006) 485-493
32. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88 (1991) 6368-6371
33. Nowicki J.P., Duval D., Poignet H., and Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204 (1991) 339-340
34. Garthwaite J., Charles S.L., and Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 (1988) 385-388
35. Satake K., Matsuyama Y., Kamiya M., Kawakami H., Iwata H., Adachi K., and Kiuchi K. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Brain Res. Mol. Brain Res. 85 (2000) 114-122
36. Xu J., Kim G.M., Chen S., Yan P., Ahmed S.H., Ku G., Beckman J.S., Xu X.M., and Hsu C.Y. INOS and nitrotyrosine expression after spinal cord injury. J. Neurotrauma 18 (2001) 523-532
37. Xu Z., Wang B.R., Wang X., Kuang F., Duan X.L., Jiao X.Y., and Ju G. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sci. 79 (2006) 1895-1905
38. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., and Michael-Titus A.T. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 26 (2006) 4672-4680
39. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., and McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22 (2002) 6570-6577